Background: Controversy exists with regard to whether to treat AO/OTA 31-A2 fractures of the proximal part of the femur
I
ntertrochanteric fractures of the proximal part of the femur have been treated successfully with use of the sliding hip screw over the last thirty years. It is accepted in the literature that this is the implant of choice for the treatment of stable (AO/OTA [Arbeitsgemeinschaft für Osteosynthesefragen/ Orthopaedic Trauma Association] 31-A1) fractures 1 , but controversy still exists with regard to the treatment of the more unstable (AO/OTA 31-A2 and A3) fractures ( Fig. 1) 
2
. There is an increasing body of evidence to indicate that reverse oblique fractures of the proximal part of the femur (A3) are best treated with use of an intramedullary device 3, 4 ; however, the optimum treatment of comminuted fractures involving the lesser tro-chanter (A2) is less clear. Parker and Handoll, in a Cochrane review article that was published in 2008, concluded from a meta-analysis of the literature that the sliding hip screw was preferable to intramedullary devices for the treatment of extracapsular fractures because of lower complication rates, but additional studies were needed for the investigation of the unstable fracture subgroup 2 . The aim of the present study was to test the hypothesis that there is no difference between the sliding hip screw (Omega 2; Stryker, Newbury, United Kingdom) and the long gamma nail Fig. 1 (Dyax; Stryker) in terms of the primary outcome measure (defined as reoperation within the first postoperative year) when used for the treatment of AO/OTA 31-A2 fractures of the proximal part of the femur. The indications for revision surgery included screw cut-out, implant failure, late fracture, and deep infection. Secondary outcomes included mortality, a requirement for transfusion, length of hospital stay, mobility, change in residence, and EuroQol 5D outcome score.
Materials and Methods
T he present study received local ethical board permission and was registered with the International Standard Randomised Control Trial Number Register (ISRCTN79362886). All patients over the age of eighteen years who had been admitted to the treating hospital with an AO/OTA 31-A2 fracture of the proximal part of the femur were considered for inclusion in the study. The exclusion criteria included pathological fractures, previous proximal femoral fractures, reverse oblique fractures (AO/OTA 31-A3), and a decision by the surgeon responsible for the patient's care not to include the patient in the study. In this last group, which comprised four patients, the decision was not made on the basis of the pathoanatomy of the fracture. At the time of admission, appropriate patients were randomized to fracture fixation with use of either a sliding hip screw or a long gamma nail. Randomization was carried out with use of sealed envelopes generated by a medical statistician. Once a patient was considered to be appropriate for inclusion, consent was obtained. An envelope was then selected and opened at a daily trauma meeting so that appropriate operative planning could be performed. A total of 300 envelopes were generated, and 210 patients were recruited. This discrepancy resulted in unequal numbers in the two recruitment arms. All able patients gave informed consent to enter the trial. Patients who were unable to provide consent were entered into the trial after discussion with the next of kin. There was no blinding of the selected treatment to either the patients or healthcare providers involved in the patients' care.
Two hundred and ten consecutive patients who met the inclusion criteria were enrolled into the trial, of whom 100 were randomized to treatment with a gamma nail and 110 were randomized to treatment with a sliding hip screw. Two patients in the long-gamma-nail group died before surgery. Figure 2 shows the flow of participants through each stage of the trial. An initial power calculation produced a sample requirement of 220 patients (as described in the Statistical Methods section), but, because of external factors, the trial was concluded after the recruitment of 210 patients.
Patients were admitted to the trauma ward and were managed with aspirin and thromboembolism-deterrent stockings for thromboprophylaxis (unless contraindicated). All patients were managed operatively at the earliest opportunity, with a consultant orthopaedic surgeon (T.M.B., R.G., C.T., W.J.H., T.J.S.C.) either performing the operation or in attendance. All surgeons had experience with the two implants, and a total of thirty-two surgeons (including five of the authors [T.M.B., R.G., C.T., W.J.H., T.J.S.C]) performed the operations. Fracture reduction was performed on a traction table before fixation. In the sliding-hip-screw group, a four-hole, 135°plate was inserted. In the long-gamma-nail group, the femur was reamed to 1 mm greater than the diameter of the nail, and a 130°nail of the appropriate length was inserted; all nails were locked distally with two screws. In all cases, efforts were made to achieve optimum positioning of the tip of the screw in the subchondral bone of the femoral head with a combined tip-apex distance measuring <25 mm on anteroposterior and lateral radiographs.
Patients were mobilized bearing full weight under the supervision of a physiotherapist. Following discharge, patients were evaluated both clinically and radiographically at three, six, and twelve months. Reoperation and mortality data were available for all patients who were included in the trial. Because of ill health, a substantial number of patients (21%) were unable to return for follow-up. In these instances, follow-up was completed at one year by means of a telephone consultation, and radiographic review was not possible.
Radiographic evaluation following fracture fixation included the measurement of the tip-apex distance, which is defined as the combined distance from the tip of the screw to the apex of the femoral head on the anteroposterior and lateral radiographs. A total distance measuring >25 mm has been shown to be associated with an increased rate of screw cut-out from the femoral head 5 .
Functional outcome was assessed with use of the EuroQol 5D questionnaire. The EuroQol 5D is a validated patient-based measure of health outcome consisting of five lifestyle questions, each scored from 1 to 3 points 6 . These scores are then entered into a formula to produce an outcome score for each patient between 20.200 (minimum score) and 1.000 (maximum score). Patients who died within the study period received a score of 0. A second component of EuroQol 5D utilizes a visual analog score (EQ VAS). Because of the large number of patients with reduced mental capacity who were included in the study, this scale was not used. EuroQol 5D outcome scores were available for 88% of the patients in the study group in the first postoperative year. The reason for the incomplete data was either inadequate completion of the EuroQol 5D questionnaire or an inability to identify a surrogate who was able to complete the questionnaire on behalf of a patient with a reduced mental capacity. Mobility and residency were scored at the time of admission and at one year on a scale of 1 to 5 (Table I ). These data were available for 88% of the patients in the trial for the reasons noted above.
Statistical Methods
The power calculation was based on the primary outcome measure of implant failure or cut-out, with anticipated failure rates of 5% for the long gamma nail and 18% for the sliding hip screw. These values were calculated from published departmental data and previous local audit 7 . A two-tailed continuitycorrected chi-squared test with 80% power and a 5% level of significance produced a required sample size of 220 patients (110 per group). Analysis of reoperation rates, mortality, tipapex distance, and transfusion rates was performed with use of regression methods. The length of hospital stay was analyzed by means of survival analysis with use of a log-rank test. EuroQol 5D scores were compared with use of linear regression on the basis of the area under the curve over a period of twelve months both before and after controlling for the mini-mental score. Because of incomplete EuroQol 5D scores for a number of patients, multiple imputation methods with eight sets of data were used to produce the mean difference between the long gamma nail and the sliding hip screw, together with confidence intervals.
Source of Funding
There was no external funding source for this project.
Results

T
he demographic and preoperative variables were comparable between the two groups, with the exception of the mini-mental score (Table II) . The long-gamma-nail group included a significantly higher proportion of patients with a reduced mini-mental score (p = 0.04). Mortality, the EuroQol 5D score, and the duration of hospital stay were found to be strongly associated with a reduced mental capacity. These outcomes were therefore corrected for the mini-mental score when comparative analyses were performed between the two groups.
The results for both groups are displayed in Table III . Two patients (2%) in the sliding-hip-screw group and three patients (3%) in the long-gamma-nail group required an additional operation. All five reoperations were performed because of screw cut-out, and there were no cases of implant failure or deep infection. There was no significant difference between the two groups with regard to the rate of the reoperation (p = 0.67). The tip-apex distance measured £25 mm in 92% of the patients in the study group. There was no difference between the two groups in terms of the mean tip-apex distance (p = 0.51). Three of the five patients requiring reoperation had a tip-apex distance of >25 mm; this proportion was significantly higher than that among patients not requiring revision surgery (7%) (p = 0.01).
There was a significant difference between the two groups in terms of the one-year mortality rate. The mortality rate at one year was 32% in the long-gamma-nail group, compared with 22% in the sliding-hip-screw group (p = 0.045; odds ratio = 1.71). However, there was no significant difference between the two groups in terms of the mortality rates after controlling for the mini-mental score (p = 0.26). There was no significant difference between the two groups with regard to length of hospital stay when corrected for the mini-mental score. There was also no difference between the groups with regard to the postoperative transfusion rate, although there was a trend for patients in the long-gamma-nail group to require more frequent transfusions (odds ratio = 1.5). EuroQol 5D scores were found to be strongly associated with the mini-mental score. The mean quality-adjusted lifeyear (QUALY) was 0.37 for the long-gamma-nail group and 0.46 for the sliding-hip-screw group. There was no significant difference between the two groups with regard to the QUALY score when adjusted for the mini-mental score (mean difference, 0.04 [95% confidence interval, -0.026 to 0.111]). Deterioration in patient mobility and independence following fracture fixation was similar between the two groups. Each patient dropped on average one level of mobility and one level of home independence following hip fracture fixation.
Discussion
O ver the last fifteen years, there has been a great deal of controversy over the optimum treatment of intertrochanteric fractures of the proximal part of the femur. The two options of extramedullary and intramedullary fixation have been studied and debated at length, with arguments over biomechanical strength, implant failure rates, periprosthetic fracture rates, ease of operation, and functional outcome 8 . Level-1 studies have suggested that the sliding hip screw is the treatment of choice for stable intertrochanteric fractures, but debate continues with regard to the optimum treatment for unstable fractures of the proximal part of the femur involving the lesser trochanter 2, 9 . The recent literature has demonstrated a change of practice in the treatment of intertrochanteric fractures, with a dramatic increase in the number of intramedullary devices being used. This increase has not been backed up by scientific evidence but has been driven by other factors, including marketing by industry, surgeon preference, and reimbursement 10 . The trend toward more frequent intramedullary fixation of intertrochanteric fractures in Medicare patients across the United States has been reported recently, but it cannot be explained by patient-related factors 11 . In a study of candidates taking the Part II American Board of Orthopaedic Surgery examination, the intramedullary fixation rate for intertrochanteric fractures increased from 3% to 67% between 1999 and 2006 12 . This increase occurred without a significant improvement in terms of functional outcome or patient satisfaction in comparison with the sliding hip screw. However, the increase in the use of intramedullary fixation was associated with a higher rate of procedure-related complications. In addition, the choice of implant has clear cost implications, with the current list price for the sliding hip screw being approximately £1000 ($1500) less than that of the long gamma nail.
It has been difficult to extract up-to-date evidence from the literature because of the evolution in the design of the intramedullary devices 13 . The relevance of early studies is limited as those studies included the original nail designs, which were subsequently modified. More recently, companies have produced variations of designs, with good results in cohort series 14, 15 . In a Cochrane review from 2008, thirty-two trials involving 5088 patients were analyzed 2 . That study demonstrated a lower complication rate for the sliding hip screw than for the intramedullary nail, the latter of which was associated with increased rates of periprosthetic fracture and reoperation.
The introduction of the newer long intramedullary nails has reduced the rate of both intraoperative fracture and subsequent femoral fracture in comparison with the rates that were seen in association with the shorter nails 16 . The present study confirms this finding, with no cases of intraoperative or postoperative fractures being observed among 100 patients who were managed with the long gamma nail. There is also a well-documented learning curve associated with intramedullary fracture fixation, after which the intraoperative complication rate decreases significantly 7, 17 . Improvements in implant design, combined with the theoretical biomechanical advantages of intramedullary fixation, have been proposed to result in a lower reoperation rate following fixation in comparison with the rate associated with the sliding hip screw. However, our findings reinforce the conclusions of a meta-analysis, published in 2006, which identified no difference in the reoperation rate after the treatment of unstable fractures with an intramedullary device or a sliding hip screw 13 . These findings may be related to the low functional demands of the elderly patients who sustain this injury. The demographic characteristics of our study group were comparable with those reported in the European and North American literature 11, 12 . Despite the presence of an osteoporotic proximal part of the femur, plate fixation with four bicortical screws appears to provide adequate fixation.
Our results suggest that the operation was performed technically correctly, with only 8% of the patients having a tipapex distance of >25 mm. The importance of the tip-apex distance is emphasized by the fact that three of the five patients who required revision surgery had a tip-apex distance in excess of the recommended upper limit of 25 mm. The importance of the tip-apex distance is likely to be greater in patients with unstable intertrochanteric fractures. In patients with stable fractures with an intact posteromedial buttress, the load is shared between the implant and the calcar femorale; however, in patients with unstable fractures, the entire load is transmitted through the implant because of the loss of this posteromedial support.
Even though only one type of nail design was studied, the results for this group were comparable with or better than those reported in other series involving other nail designs 2 . A multicenter study 18 evaluating the results of the Proximal Femoral Nail (PFNA; Synthes, Hertfordshire, United Kingdom) for the treatment of 31-A1 and 31-A2 fractures in 315 patients demonstrated that forty-six patients (15%) had implant complications, with an overall reoperation rate of 9%. The authors of that study concluded that the proximal femoral nail with a helical blade should be the implant of choice for the treatment of these fractures. That study contained no control arm, and as a result one is not able to draw conclusions with regard to the optimum treatment of this fracture pattern. In a study evaluating the VeroNail (Orthofix, Verona, Italy) with locked converging screws, patients with unstable proximal femoral fractures had the same function as those managed with a sliding hip screw 19 . The strengths of the present study include the randomization of >98% of the patients who were suitable for inclusion and the fact that the primary outcome was available in all cases. An additional strength was the inclusion of patients with a reduced mental capacity, with approximately half of the patients in the present study having a reduced mental capacity. As a consequence of this high proportion of patients with a reduced mental capacity and the general poor health of the study population, the rate of attendance for clinical review was reduced. Despite obtaining a telephone interview with many of these patients or their caregivers, there is a possibility that we did not identify patients with minimum symptoms who would have had evidence of implant failure or cut-out if radiographs had been made. Another weakness of the present study is that recruitment did not quite reach the initial power calculation as has been discussed in the methodology. Additional weaknesses were that the patients and healthcare providers were not blinded to the treatment method and that there was a lack of detailed data on the length of operating time and on intraoperative blood loss.
In conclusion, our study identified no difference in the reoperation rate following the fixation of AO/OTA 31-A2 fractures of the proximal part of the femur with a long gamma nail or a sliding hip screw. Furthermore, no difference was identified between the two groups with regard to quality of life as measured with EuroQol 5D outcome scores at one year. We conclude that the sliding hip screw should remain the gold standard for the treatment of such fractures. n
